CRO Vaccine expertise & emerging market access: what’s the value for companies entering into the clinical research arena?

Emerging Markets are key to vaccine development, CRO partners understanding of the challenges involved and knowledge of how to overcome them is key to the success of any trial. Join us on the 11th April to hear from Mark Wood, Associate Director for Proposals & Business Intelligence at Encorium to understand why the range of experience from developing Clinical Developments Plans through to study execution and market launch are important considerations when selecting a CRO partner.


What efficiencies are gained by collaborating with your CRO at an early stage?


All this and much more will be discussed on April 11th 2012.


Get your questions ready!


Have a look at the Congress program here.


Ensure you join us at the event at the best possible ticket price by booking your place before the end of the week!! – register here.


Leave a Reply

Your email address will not be published. Required fields are marked *